HB9 are sequence-specific DNA-binding proteins that have been implicated in the control of gene expression both in developing as well as in adult tissues; a putative transcription factor involved in pancreas development and function. HB9, was found to be highly expressed in bone marrow cells enriched for CD34-positive cells, present at low levels in unfractionated bone marrow cells, and essentially undetectable in bone marrow cells depleted of CD34 cells. Studies show differentiation of CD34-positive cells along a specific cell lineage likely requires
downregulation of both HB24 and HB9 (1).
Suitable for use in Western Blot and Immunoprecipitation. Other applications not tested.
Western Blot: 1:200,000-1:500,000
Optimal dilutions to be determined by the researcher.
Storage and Stability:
May be stored at 4 degrees C for short-term only. For long-term storage, aliquot and store at -20 degrees C. Aliquots are stable for at least 12 months at -20 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Manufactured incorporating RabMAb(R) technology under Epitomics US patents, No 5,675,063 and 7,429,487, owned by Abcam.